One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias

Research output: Contribution to journalArticle

Elizabeth Geddes-Bruce, Selina S. Hamill, Christopher B. Zachary, Paul Friedman

Objectives: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device. Methods: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects’ current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed. Results: Of the subjects with available follow-up data, 44% maintained “complete vessel clearance,” 44% dropped down one grade to “almost complete vessel clearance,” and 11% dropped down to “moderately clear vessel clearance.” All showed clinically significant improvement in nasal telangiectasias from baseline. Conclusions: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61–63, 2018.

Original languageEnglish (US)
Pages (from-to)61-63
Number of pages3
JournalLasers in Surgery and Medicine
Volume50
Issue number1
DOIs
StatePublished - Jan 1 2018

PMID: 29171039

Altmetrics

Cite this

Standard

One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias. / Geddes-Bruce, Elizabeth; Hamill, Selina S.; Zachary, Christopher B.; Friedman, Paul.

In: Lasers in Surgery and Medicine, Vol. 50, No. 1, 01.01.2018, p. 61-63.

Research output: Contribution to journalArticle

Harvard

Geddes-Bruce, E, Hamill, SS, Zachary, CB & Friedman, P 2018, 'One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias' Lasers in Surgery and Medicine, vol. 50, no. 1, pp. 61-63. https://doi.org/10.1002/lsm.22765

APA

Geddes-Bruce, E., Hamill, S. S., Zachary, C. B., & Friedman, P. (2018). One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias. Lasers in Surgery and Medicine, 50(1), 61-63. https://doi.org/10.1002/lsm.22765

Vancouver

Geddes-Bruce E, Hamill SS, Zachary CB, Friedman P. One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias. Lasers in Surgery and Medicine. 2018 Jan 1;50(1):61-63. https://doi.org/10.1002/lsm.22765

Author

Geddes-Bruce, Elizabeth ; Hamill, Selina S. ; Zachary, Christopher B. ; Friedman, Paul. / One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias. In: Lasers in Surgery and Medicine. 2018 ; Vol. 50, No. 1. pp. 61-63.

BibTeX

@article{d5e01443ffea41f795ebce6bf2e1da82,
title = "One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias",
abstract = "Objectives: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device. Methods: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects’ current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed. Results: Of the subjects with available follow-up data, 44{\%} maintained “complete vessel clearance,” 44{\%} dropped down one grade to “almost complete vessel clearance,” and 11{\%} dropped down to “moderately clear vessel clearance.” All showed clinically significant improvement in nasal telangiectasias from baseline. Conclusions: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61–63, 2018.",
keywords = "laser, telangiectasias, TRASER, vessels",
author = "Elizabeth Geddes-Bruce and Hamill, {Selina S.} and Zachary, {Christopher B.} and Paul Friedman",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/lsm.22765",
language = "English (US)",
volume = "50",
pages = "61--63",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley",
number = "1",

}

RIS

TY - JOUR

T1 - One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias

AU - Geddes-Bruce, Elizabeth

AU - Hamill, Selina S.

AU - Zachary, Christopher B.

AU - Friedman, Paul

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objectives: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device. Methods: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects’ current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed. Results: Of the subjects with available follow-up data, 44% maintained “complete vessel clearance,” 44% dropped down one grade to “almost complete vessel clearance,” and 11% dropped down to “moderately clear vessel clearance.” All showed clinically significant improvement in nasal telangiectasias from baseline. Conclusions: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61–63, 2018.

AB - Objectives: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device. Methods: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects’ current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed. Results: Of the subjects with available follow-up data, 44% maintained “complete vessel clearance,” 44% dropped down one grade to “almost complete vessel clearance,” and 11% dropped down to “moderately clear vessel clearance.” All showed clinically significant improvement in nasal telangiectasias from baseline. Conclusions: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61–63, 2018.

KW - laser

KW - telangiectasias

KW - TRASER

KW - vessels

UR - http://www.scopus.com/inward/record.url?scp=85040771116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040771116&partnerID=8YFLogxK

U2 - 10.1002/lsm.22765

DO - 10.1002/lsm.22765

M3 - Article

VL - 50

SP - 61

EP - 63

JO - Lasers in Surgery and Medicine

T2 - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 1

ER -

ID: 39164016